Cardiac Arrest Induced by Anti-Bradycardia and Anti-Tachycardia Therapies of an Implantable Cardioverter Defibrillator

Implantable cardioverter-defibrillators (ICD) can terminate ventricular tachy-arrhythmias (VTs) with shocks or antitachycardia pacing (ATP). Lots of studies demonstrated that ATP terminates most of VTs but with a 1% to 7% risk of acceleration or precipitation of these arrhythmias. Also, anti-bradycardia therapy can have an intrinsic arrythmogenic risk.


Mauro Toniolo, Elisabetta Daleffe, Luca Rebellato, Domenico Facchin and Alessandro Proclemer

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • World Heart Congress
    April 19-20, 2018 Amsterdam, Netherlands
  • Cardiovascular Medicine and Cardiac Surgery
    July 05-06, 2018 Berlin, Germany
  • International Conference on Cardiovascula r Imaging
    July 11-12, 2018 Sydney,Australia
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • Google Scholar
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat